SONIA RUPP: Open Payments
NPI 1548486699 · STATELINE, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$447 in 22 payments from 10 companies in 2025. Trend: 2023 $183 · 2024 $460 · 2025 $447
Food & beverage: $447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $127 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Alkermes, Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Indivior Inc. | 1 | $18 |
Products named: VRAYLAR, AUSTEDO XR, COBENFY, ABILIFY MAINTENA, Qelbree, ARISTADA, INGREZZA, Jornay PM.
Industry payments across NV — which companies pay providers there.
